CN1106393C - Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process - Google Patents

Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process Download PDF

Info

Publication number
CN1106393C
CN1106393C CN00127945A CN00127945A CN1106393C CN 1106393 C CN1106393 C CN 1106393C CN 00127945 A CN00127945 A CN 00127945A CN 00127945 A CN00127945 A CN 00127945A CN 1106393 C CN1106393 C CN 1106393C
Authority
CN
China
Prior art keywords
optically active
synthetic method
organic bases
active beta
furanones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN00127945A
Other languages
Chinese (zh)
Other versions
CN1299816A (en
Inventor
麻生明
施章杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN00127945A priority Critical patent/CN1106393C/en
Publication of CN1299816A publication Critical patent/CN1299816A/en
Application granted granted Critical
Publication of CN1106393C publication Critical patent/CN1106393C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to beta-aryl substitution-2(5H)-furanone with optical activity and a synthetic method thereof, namely that in non-polar solvent, the beta-aryl substitution-2(5H)-furanone is prepared from 1.2 to 6% of aryl iodide and 1% of salt prepared from 2, 3-diolefine acid and chiral organic alkali by reaction at 0 to 25 DEG C under the catalysis of 0.05 to 0.10% of Pd(0) catalyst in the charge ratio. The yield of corresponding beta-aryl substitution-2(5H)-furanone synthesized by the method is from 55 to 90%, and an ee value can reach 91 to 97%. The method has the advantages of mild reaction condition, high yield, single product and easy separation and purification.

Description

A kind of have optically active β one aryl and replace-2 (5H)-furanone and synthetic methods thereof
The present invention relates to the five-membered ring unsaturated lactone compound that a kind of β position is replaced by aryl, have promptly that optically active beta-aromatic replaces-2 (5H)-furanones and under Pd (O) catalysis aryl iodide and 2, the method for synthesizing this compounds of the reactant salt that 3-di-olefin(e) acid and chirality organic bases generate.
The five-membered ring unsaturated lactone is one of modal structure component in the natural product, has multiple important physical activity.Its antisepsis and anti-inflammation, antimycotic, antitumor, and regulate effects such as seed germination and plant-growth and gained public acceptance, at aspects such as medicine and agricultural chemicals huge value of exploiting and utilizing is arranged.The efficient succinct synthetic of this compounds is the focus of people's common concern always.2 (5H)-Furanones compounds that optically active polyaryl/alkyl replaces may have the more strong physiologically active that racemic this compounds does not have on the one hand, also can overcome on the other hand because a lot of side effects that another optical isomer brought.Two enantiomorphous optical isomers of existing report not only may reduce the performance of medicine on the document, more have some harmful side effects, as the fetus teratogenesis etc.Therefore, synthetic to the chirality of compound with chiral centre, be the particularly problem paid close attention to of Pharmaceutical Chemist of chemist.J.Am.Chem.Sioc.1989 for example, 111,2204; J.Org.Chem.1988, the synthetic of 2 (5H)-Furanones compounds that disclosed optically active polyaryl in 53,4393/alkyl replaces is to prepare from the chiral substrates that is difficult to obtain.Therefore synthetic high biological activity has 2 (5H)-Furanones compounds that optically active polyaryl/alkyl replaces, seeks and prepare this compounds from the chiral source that simply is easy to get, a cheapness, efficient and practical method are provided, still all have positive meaning from experimental implementation safety from the angle of economy.
The object of the invention just provides a kind of optically active beta-aromatic and replaces-2 (5H)-furan ketone compounds, and its molecular formula is:
Figure C0012794500031
Wherein: R 1=H, Ph; R 2=Ph, p-BrPh, C nH 2n+1, n=0-7; R 3=Ar; R 4=C mH 2m+1, m=0-5.
Another object of the present invention just provides the correlation method of synthetic this compounds, promptly under Pd (O) catalysis, and aryl iodide ArI and 2, the salt of 3-di-olefin(e) acid and the generation of chirality organic bases Reaction obtains optically active beta-aromatic and replaces-2 (5H)-furanones, and reaction formula is as follows:
Figure C0012794500042
Concrete reaction conditions is: in non-polar solvent, and under certain temperature condition, aryl iodide and 2, the salt that 3-di-olefin(e) acid and chirality organic bases generate is through catalyzed reaction 24-72 hour gained of Pd (O).Wherein non-polar solvent is toluene, benzene, dimethylbenzene, normal hexane, hexanaphthene etc.; Temperature of reaction is 0-25 ℃, is recommended as 0-5 ℃; Pd (O) catalyzer is Pd 2(dba) 3CHCl 3(dba is trans 1,5-phenyl-1, and 4-pentadiene-3-ketone, structural formula is , Pd (PPh 3) 4, allyl palladium chloride, consumption are 5-10mol%; The chirality organic bases is the chirality organic bases of synthetic such as natural organic bases such as cinchovatin, cinchonine and D/L-Alpha-Methyl benzylamine; 2, the feed ratio of the salt that 3-connection olefin(e) acid and chirality organic bases generate, aryl iodide, Pd (O) catalyzer is 1: 1.2-6: 0.05-0.10.
Synthesis of optically active beta-aromatic provided by the invention replaces the method for-2 (5H)-furanones, compared with prior art have following characteristics: reaction uses generate polysubstituted 2 (the 5H)-furanones of high optical activity one step of chiral source that cheaply is easy to get, and the chirality organic bases of use can be recycled; The reaction conditions gentleness, yield is higher, and product is single, is easy to separation and purification; Conversion unit is simple, and cost is low, is easy to industrialization.For the height of realizing this compounds has improved one efficiently, simple approach to selectivity is synthetic.
Following examples help to understand the present invention, but are not limited to content of the present invention.
Embodiment 1
0.1mmol, the 4-phenyl-2-methyl-2 of L-(-)-cinchovatin of 97%ee, 3-divinyl hydrochlorate, 0.12mmol iodobenzene are dissolved in the 3ml toluene, are cooled to-78 ℃, add 5mol%Pd then rapidly 2(dba) 3CHCl 3With the 20mol% triphenylphosphine, be warming up to 0 ℃, stirred 2 days, reaction mixture is directly purified through column chromatography, get pale yellow oily liquid body 22.5mg, yield is 90%, product is (+)-4,5-phenylbenzene-3-methyl-2 (5H)-furanone, data are as follows:
The ee value is 91%;
1H NMR (300MHz, CDCl 3) δ ppm, 7.12-7.38 (m, 10H), 6.19 (s, 1H), 2.17 (s, 3H); Ms (EI, M/e): 250 (M +, 42.33), 145 (100); IR (pure) 1746,1648,1010cm -1
Embodiment 2
Reactions steps and reaction conditions are with embodiment 1, and reactant is 0.1mmol, the 4-phenyl-2-methyl-2 of 97%ee L-(-)-Alpha-Methyl benzylamine, and 3-divinyl hydrochlorate and 0.3mmol iodobenzene are dissolved in the 4ml dimethylbenzene, add the Pd (PPh of 8mol% 3) 4, stirring 36 hours, its yield is 85%, product is with embodiment 1,
The ee value is 93%;
Other data are with embodiment 1.
Embodiment 3
Reactions steps and reaction conditions are with embodiment 1, reactant is 0.1mmol, 4-phenyl-2-the methyl-2 of the D-(+) of 98%ee-Alpha-Methyl benzylamine, 3-divinyl hydrochlorate and 0.24mmol iodobenzene are dissolved in the 3ml hexanaphthene, add the 10mmol% allyl palladium chloride, be warming up to 10 ℃ and stirred 24 hours down, get the pale yellow oily liquid body, productive rate is 66%, product is (-)-4,5-phenylbenzene-3-methyl-2 (5H)-furanone.
The ee value is 96%;
1H?NMR(300MHz,CDCl 3)δppm,7.08-7.40(m,10H),6.19(s,1H),2.14(s,3H)。
Embodiment 4
With 0.01mmol, 4-phenyl-2-the methyl-2 of L-(-)-cinchovatin of 97% ee, 4-phenyl-2-the methyl-2 of the L-(-) of 3-divinyl hydrochlorate or 97% ee-Alpha-Methyl benzylamine, 3-divinyl hydrochlorate and 0.02mmol are dissolved in the 4ml benzene toluene iodide, be cooled to-78 ℃, add 5mol%Pd then rapidly 2(dba) 3CHCl 3With the 20mol% triphenylphosphine, be warming up to 5 ℃, stirred 24 hours, obtain weak yellow liquid, productive rate and ee% are respectively 66%, 92% ee or 65%, 91%ee.The data of (+)-3-methyl-4-(4 '-aminomethyl phenyl)-5-phenyl-2 (5H)-furanone are as follows:
1H?NMR(300MHz,CDCl 3)δppm,7.03-7.18(m,9H),6.06(s,1H),2.20(s,3H),2.02(d,J=1.4Hz,3H);
Ms(EI,M/e)264(M +,44.76),159(100);
IR (pure) 1746,1650,1610,1092,1030cm -1
HRMS?C 18H 16O 2
Calculated value: 264.1146, measured value: 264.11403.
Embodiment 5
Reactions steps and reaction conditions are with embodiment 4, reactant is 0.1mmol, 4-phenyl-2-the methyl-2 of the D-(+) of 98% ee-Alpha-Methyl benzylamine, 3-divinyl hydrochlorate and 0.4mmol are to toluene iodide, productive rate is 72%, the pale yellow oily liquid body, the data of product (-)-3-methyl-4-(4 '-aminomethyl phenyl)-5-phenyl-2 (5H)-furanone are as follows:
Ee value: 97%;
1H?NMR(300MHz,CDCl 3)δppm,7.03-7.18(m,9H),6.06(s,1H),2.20(s,3H),2.02(d,J=1.4Hz,3H);
Ms(EI,M/e)264(M +,44.76),159(100);IR(neat)1746,1650,1610,1092,1030cm -1
Embodiment 6
Reactions steps and reaction conditions are with embodiment 2, reactant is 0.1mmol, 4-phenyl-2-n-propyl-2 of 98%ee, 3-divinyl acid L-(-)-cinchovatin connection olefin(e) acid salt and 0.5mmol iodobenzene, product is a weak yellow liquid, productive rate is 72%, and product is (+)-4,5-phenylbenzene-3-n-propyl-2 (5H)-furanone.Data are as follows:
Ee value: 91%;
1H?NMR(300MHz,CDCl 3)δppm,7.11-7.39(m,10H),6.13(s,1H),2.45-2.56(m,2H),1.64-1.80(m,2H),1.00(t,J=7.5Hz);
Ms(EI,m/e)278(M+,71.55),173(100),115(99.13);
IR (pure) 1746,1648,1098,1010cm -1
HRMS?C 19H 18O 2
Calculated value: 278.1302, measured value: 278.12916.
Embodiment 7
Reactions steps and reaction conditions are with embodiment 3, reactant is 0.1mmol, the L-(-) of 98% ee-cinchovatin 4-phenyl-2-n-propyl-2,3-divinyl hydrochlorate and 0.12mmol are to toluene iodide, product is a weak yellow liquid, productive rate is 75%, and product (+)-3-n-propyl-(4 '-aminomethyl phenyl)-5-phenyl-2 (5H)-furanone data are as follows:
Ee value: 91%;
1H?NMR(300?MHz,CDCl 3)δ?ppm,7.08-7.30(m,9H),6.12(s,1H),2.45-2.53(m,2H),2.29(s,3H),1.60-1.74(m,2H),0.98(t,J=7.4Hz);
Ms(EI,M/e)292(M +,70.80),187(100);
IR (pure) 1746,1648,1098,1010cm -1
HRMS?C 20H 20O 2
Calculated value: 292.1458, measured value: 292.1449.
Embodiment 8
Reactions steps and reaction conditions embodiment 4, reactant are 0.1mmol, the L-(-) of 97% ee-cinchovatin 2, the iodobenzene of 3-diene ten-hydrochlorate and 0.3mmol is dissolved in the 5ml hexanaphthene, add allyl palladium chloride 10mmol%, reaction obtains weak yellow liquid under the room temperature, and productive rate is 75%; The data of product (+)-4-phenyl-5-n-heptyl-2 (5H)-furanone are as follows:
Ee value: 94%;
1H?NMR(300MHz,CDCl 3)δppm,7.44-7.53(m,5H),6.28(s,1H),5.42-5.50(m,1H),1.92-2.03(m,1H),1.49-1.60(m,1H),1.11-1.48(m,10H),0.85(t,J=6.7Hz)。
Embodiment 9
With 0.01mmol, the 4-phenyl-2-methyl-2 of the D-(+) of 98%ee-Alpha-Methyl benzylamine in 3-divinyl hydrochlorate and the 0.06mmol 4-Iodobenzoic acid methyl esters dissolving 5ml normal hexane, adds 5mol%Pd 2(dba) 3CHCl 3With the 20mol% triphenylphosphine, be warming up to 15 ℃, stirred 30 hours, productive rate is 58%. white solids, the data of product (-)-3-methyl-4-(4 '-methoxycarbonyl phenyl)-5-phenyl-2 (5H)-furanone are as follows:
The ee value is 94%;
mp:43.5-45℃;
1H?NMR(300MHz,CDCl 3)δppm?7.92(d,J=8.3Hz,2H),7.03-7.22(m,7H),6.06(s,1H),3.78(s,3H),2.04(s,3H);
Ms(EI,M/e)308(M+,69.26),203(100);
IR(KBr)1748,1746,1608,1028cm -1
HRMS?C 19H 16O 4
Calculated value: 308.1044, measured value: 308.10438.

Claims (6)

1, a kind of have optically active beta-aromatic and replace-2 (5H)-furanones, it is characterized in that the compound molecule general formula is:
Figure C0012794500021
Wherein: R 1=H, Ph; R 2=Ph, p-BrPh, C nH 2n+1, n=0-7; R 3=Ar; R 4=C mH 2m+1, m=0-5.
2, a kind of synthetic method that optically active beta-aromatic replaces-2 (5H)-furanones that has, it is characterized in that in non-polar solvent, under 0-25 ℃ temperature condition, aryl iodide and 2, the salt that 3-di-olefin(e) acid and chirality organic bases generate is under the catalysis of Pd (O) catalyzer, reaction obtains optically active beta-aromatic and replaces-2 (5H)-furanones, and its reaction formula is as follows:
Figure C0012794500022
Wherein: R 1=H, Ph; R 2=Ph, p-BrPh, C nH 2n+1, n=0-7; R 4=C mH 2m+1, m=0-5; B is the chirality organic bases; 2, the feed ratio of the salt that 3-connection olefin(e) acid and chirality organic bases generate, aryl iodide, Pd (O) catalyzer is 1: 1.2-6: 0.05-0.10.
3, synthetic method as claimed in claim 1 or 2 is characterized in that non-polar solvent is toluene, benzene, dimethylbenzene, normal hexane, hexanaphthene.
4, synthetic method as claimed in claim 1 or 2 is characterized in that the chirality organic bases is cinchovatin, cinchonine and D/L-Alpha-Methyl benzylamine.
5, synthetic method as claimed in claim 1 or 2 is characterized in that Pd (O) catalyzer is Pd 2(dba) 3CHCl 3, Pd (PPh 3) 4, allyl palladium chloride, consumption is 5-10mol%.
6, synthetic method as claimed in claim 1 or 2 is characterized in that temperature of reaction is 0-5 ℃.
CN00127945A 2000-12-19 2000-12-19 Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process Expired - Fee Related CN1106393C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00127945A CN1106393C (en) 2000-12-19 2000-12-19 Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00127945A CN1106393C (en) 2000-12-19 2000-12-19 Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process

Publications (2)

Publication Number Publication Date
CN1299816A CN1299816A (en) 2001-06-20
CN1106393C true CN1106393C (en) 2003-04-23

Family

ID=4592855

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00127945A Expired - Fee Related CN1106393C (en) 2000-12-19 2000-12-19 Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process

Country Status (1)

Country Link
CN (1) CN1106393C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87103274A (en) * 1986-05-05 1988-01-20 威廉施瓦布博士有限公司 5-aralkyl-4-alkoxyl group-2 (5H)-furanone, intermediate product and preparation method thereof and as the use of medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87103274A (en) * 1986-05-05 1988-01-20 威廉施瓦布博士有限公司 5-aralkyl-4-alkoxyl group-2 (5H)-furanone, intermediate product and preparation method thereof and as the use of medicine

Also Published As

Publication number Publication date
CN1299816A (en) 2001-06-20

Similar Documents

Publication Publication Date Title
CN1821242A (en) Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor
CN1366526A (en) Process for preparation of pure citalopram
CN1705664A (en) Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
CN1290818C (en) Method for asymmetrical hydrogen transfer of alpha-imino keton for synthesizing chirality salbutamol
CN1121381C (en) Novel process for preparing ketimine
CN1063422C (en) Production of optically active 2-halo-1-(substituted phenyl) ethanol and substituted styrene oxide
CN1276911C (en) New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method
CN1025328C (en) Process for preparing sertraline intermediates
CN1106393C (en) Optically active beta-aryl substitution-2(5H)-ketofuran and its synthesis process
CN1268889A (en) Novel process for obtg. intermediates
CN1765892A (en) Orlistat preparation method
CN102286036A (en) Synthesis method of rhodioside
CN1161353C (en) Process for production of paroxetine
CN1182113C (en) 2,5-cis-bisubstituted pyrrolidine derivative and its preparing process and usage
CN1675200A (en) Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
CN1266155C (en) 6-chloro-4-hydroxy-2-methyl-2H-thieno-(2,3-e)-1,2-thiazine-1,1-dioxide-3
CN101709313B (en) Method for catalytic synthesizing beta-nitroalcohol compounds by using lipase in organic phase
CN1102587C (en) Optically active beta-halo-gamma-crotonic lactone and its synthesis process
CN1176924C (en) Chirality catalyst for oxidative coupling naphthol
CN1062552C (en) Cyclohexadiene derivatives
CN1727329A (en) New method for synthesizing Gabapentin hydrochloride
CN1348437A (en) A method of preparing cyclohexanecaraboxylic acid using [2+4] Diels-Alder reaction
CN1102586C (en) Gamma-butenolide containing aryl substituent at beta position and its solid-phase synthesis process
CN1955185A (en) Optical active substitution oxyphosphonate salt acetate and its use
CN1189458C (en) Method for producing high purity antimer of (2s,3s)-1-tert-butoxy carbonyl-3-hydroxy-2-phenyl piperidine

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030423

Termination date: 20151219

EXPY Termination of patent right or utility model